Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload
NCT01335035
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Iron Overload
Interventions
DRUG:
deferasirox
Sponsor
Novartis Pharmaceuticals